ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.45−0.27 (-7.26%)

Close on Nov 12, 2026Market cap $39.16MP/E –Yield –

ImageneBio ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

ImageneBio's ebitda for the twelve months ending Sep 30, 2026 was -$49.68M. For fiscal 2025 it was -$48.05M.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$48.05M	–
FY2024	Dec 31, 2024	-$35.90M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$17.31M	–
Q2 FY2026	Jun 30, 2026	-$11.78M	–
Q1 FY2026	Mar 31, 2026	-$12.08M	–
Q4 FY2025	Dec 31, 2025	-$8.51M	–
Q3 FY2025	Sep 30, 2025	-$26.19M	–
Q2 FY2025	Jun 30, 2025	-$7.36M	–
Q1 FY2025	Mar 31, 2025	-$5.99M	–
Q4 FY2024	Dec 31, 2024	-$6.16M	–